SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017291
Filing Date
2019-05-08
Accepted
2019-05-08 16:55:07
Documents
60
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q alrn-10q_20190331.htm 10-Q 1821902
2 EX-31.1 alrn-ex311_6.htm EX-31 16323
3 EX-31.2 alrn-ex312_7.htm EX-31 16138
4 EX-32.1 alrn-ex321_9.htm EX-32 7917
5 EX-32.2 alrn-ex322_8.htm EX-32 6937
  Complete submission text file 0001564590-19-017291.txt   6166035

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alrn-20190331.xml EX-101.INS 1305073
7 XBRL TAXONOMY EXTENSION SCHEMA alrn-20190331.xsd EX-101.SCH 41034
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20190331_cal.xml EX-101.CAL 44411
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20190331_def.xml EX-101.DEF 126762
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20190331_lab.xml EX-101.LAB 345540
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20190331_pre.xml EX-101.PRE 267337
Mailing Address 490 ARSENAL WAY WATERTOWN MA 02472
Business Address 490 ARSENAL WAY WATERTOWN MA 02472 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 19807419
SIC: 2834 Pharmaceutical Preparations